- HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathway
Le Yin et al, 2023, Human Cell CrossRef - RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1
Adam Azlan et al, 2023, Medical Oncology CrossRef - Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
Nikola Curik et al, 2021, Frontiers in Oncology CrossRef - High STAT5A Expression is Associated with Major Molecular Response Achievement Failure of Chronic Phase Chronic Myeloid Leukemia Patients Receiving Hydroxyurea before Imatinib: A Cross-sectional Study
Ikhwan Rinaldi et al, 2021, Open Access Macedonian Journal of Medical Sciences CrossRef - Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
Aierpati Maimaiti et al, 2022, Frontiers in Molecular Biosciences CrossRef - Identifying Dysregulated lncRNA-Associated ceRNA Network Biomarkers in CML Based on Dynamical Network Biomarkers
Junhua Xu et al, 2020, BioMed Research International CrossRef